Roivant Sciences Ltd. (ROIV)
$33.35-3.58%Close
SELLBEAR · day 9
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $24.1B
- Beta
- 1.10
- P/E (TTM)
- -87.76
- Short % float
- 6.81%
- Days to cover
- 4.4
- SI change
- +8.6%
- 1W
- -6.14%
- 1M
- -18.70%
- vs SPY 1W
- -6.00%
- vs SPY 1M
- -21.20%
Industry peers
FMP comparable companies · ranked by market cap
- VRTXSELLVertex Pharmaceuticals Incorporated$129.5BBEARQ 23$510.08-4.30%
- MRNABUYModerna, Inc.$89.3BRECOVERYQ 36$225.00+1.17%
- REGNSELLRegeneron Pharmaceuticals, Inc.$76.9BBEARQ 24$746.54-1.27%
- BIIBBUYBiogen Inc.$33.3BBULLQ 19$225.71-0.22%
- ALNYSELLAlnylam Pharmaceuticals, Inc.$31.1BRECOVERYQ 28$232.68-1.41%
- BNTXSELLBioNTech SE$24.4BCRISISQ 35$96.96-7.13%
- UTHRBUYUnited Therapeutics Corporation$23.3BRECOVERYQ 20$549.16-1.22%
- INCYSELLIncyte Corporation$22.9BBEARQ 13$112.79-2.46%
- GMABBUYGenmab A/S$22.8BBULLQ 21$37.07-2.14%
- JAZZSELLJazz Pharmaceuticals plc$13.7BBEARQ 24$218.42-2.93%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 3
- VALUE
- 0
- GROWTH
- 19
- GARP
- 4
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-3.7%
REV YoY-
ROE-6.1%
EPS YoY-
ROA-5.0%
GROSS81
OP-18141
NET-3535
[VALUATION]
P/E TTM-87.76
P/E FWD-
SECTOR PE20.34
INDUSTRY PE13.84
P/B5.68
P/FCF-
EV/EBITDA-79.96
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E2.53
ALTMAN Z-
CURR RATIO16.72
ND/EBITDA-
BETA1.10
Company news
FAQ
- What is LOPJLB’s current signal on ROIV?
- LOPJLB’s latest quantitative signal on Roivant Sciences Ltd. (ROIV) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is ROIV in?
- Roivant Sciences Ltd. (ROIV) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Roivant Sciences Ltd. (ROIV) do?
- Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company dedicated to discovering and advancing innovative therapeutic drugs. The firm's development pipeline targets a broad spectrum of diseases, including various forms of solid tumors and oncologic malignancies, hematological disorders like sickle cell disease and warm autoimmune hemolytic anemia, as well as rare conditio…